Boehringer Ingelheim registers Phase III trial investigating verducatib in COPD

The Phase III AIRWARD™ trial was published today on ClinicalTrials.gov (NCT07907991).1AIRWARD will evaluate the efficacy and safety of verducatib, an investigational oral therapy…

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.thestar.com)